Reviva Pharmaceuticals Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Reviva Pharmaceuticals Stock Summary

Reviva Pharmaceuticals competes with Protalix Biotherapeutics, Eyepoint Pharmaceuticals, Sellas Life, In8bio, and Cue Biopharma. Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. It is also developing RP1208 that is in pre-clinical development studies for the treatment of depression and obesity. Reviva Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 5 people.

Reviva Pharmaceuticals Key Financial Ratios

Reviva Pharmaceuticals Key Balance Sheet Accounts

Reviva Pharmaceuticals Key Income Statement Accounts

Reviva Pharmaceuticals Key Cash Accounts

Reviva Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Reviva Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Reviva Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Reviva Pharmaceuticals competition to find correlations between indicators driving Reviva Pharmaceuticals's intrinsic value. More Info.Reviva Pharmaceuticals Holdings is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . As of now, Reviva Pharmaceuticals' Return On Equity is decreasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Reviva Pharmaceuticals' earnings, one of the primary drivers of an investment's value.

Reviva Pharmaceuticals Systematic Risk

Today, most investors in Reviva Pharmaceuticals Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Reviva Pharmaceuticals' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Reviva Pharmaceuticals growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Reviva Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Reviva Pharmaceuticals Holdings. We use our internally-developed statistical techniques to arrive at the intrinsic value of Reviva Pharmaceuticals Holdings based on widely used predictive technical indicators. In general, we focus on analyzing Reviva Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Reviva Pharmaceuticals's daily price indicators and compare them against related drivers.

When running Reviva Pharmaceuticals' price analysis, check to measure Reviva Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Reviva Pharmaceuticals is operating at the current time. Most of Reviva Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Reviva Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Reviva Pharmaceuticals' price. Additionally, you may evaluate how the addition of Reviva Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.